Patents by Inventor David F. Eierman

David F. Eierman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment using prostoglandin and particulate formulations
    Patent number: 6030639
    Abstract: Provided herein is a method of administering a free arachidonic acid metabolite to an animal, the method involving administration of the free metabolite and an endocytosable particle. This method can be used to treat animals afflicted with disorders characterized by cell activation and adhesion, inflammation or toxemia. Also provided is a method of treating a animal for such disorders by administration to the animals of a composition containing an anti-disorder effective amount of an endocytosable particle.
    Type: Grant
    Filed: May 23, 1996
    Date of Patent: February 29, 2000
    Assignee: The Liposome Company, Inc.
    Inventors: Andrew S. Janoff, David F. Eierman
  • Treatment using arachidonic acid metabolite and particulate formulations
    Patent number: 5840328
    Abstract: A composition comprises a free arachidonic acid metabolite and endocystosable particles such as phagocytosable or opsonizable particles, or particles binding to phagocytic receptors to serum proteins, and the like. The composition, in the form of a therapeutic formulation may be administered alone, or with other bioactive agents, for the treatment of a disorder characterized by cell activation/adhesion, inflammation or toxemia. A second method of treating such disorders comprises the administration of an endocytosable particle.
    Type: Grant
    Filed: January 11, 1995
    Date of Patent: November 24, 1998
    Assignee: The Liposome Company, Inc.
    Inventors: Andrew S. Janoff, David F. Eierman